In technology that promises to one day allow drug delivery to be tailored to an individual patient and a particular cancer tumor, researchers have developed an efficient system for delivering siRNA into primary cells.
In technology that promises to one day allow drug delivery to be tailored to an individual patient and a particular cancer tumor, researchers have developed an efficient system for delivering siRNA into primary cells.